ESR1 and neoplasm: Although ER-RTK crosstalk is a classic topic in growth factor-induced tumor promotion, the results from our experiments are implicated to palbociclib resistance in multiple ways: (1) in context with FGFRs/FGFs induced regulation of ER signaling [45], our data supports ER activation as a fundamental mechanism involved in palbociclib resistance.